Description
Contents
Empagliflozin
Indications/Uses
Type 2 diabetes mellitus: Glycaemic control: Jardiance is indicated in the treatment of type 2 diabetes mellitus to improve glycaemic control in adults as: Monotherapy: When diet and exercise alone do not provide adequate glycaemic control in patients for whom use of metformin is considered inappropriate due to intolerance.
Heart failure: Jardiance is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure.
Dosage/Direction for Use
Type 2 diabetes mellitus: The recommended starting dose is 10 mg empagliflozin once daily for monotherapy and add-on combination therapy with other glucose-lowering medicinal products. In patients tolerating empagliflozin 10 mg once daily and need tighter glycaemic control, the dose can be increased to 25 mg once daily. The maximum daily dose is 25 mg (see as follows and Precautions).
Heart failure: The recommended dose is 10 mg empagliflozin once daily.
Heart failure: The recommended dose is 10 mg empagliflozin once daily.
*The product images shown are for illustration purposes only and may not be an exact representation of the product.
